Date:4/3/2009

s and are generally identified by the words "may," "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates," "could," "would," and similar expressions. Because these forward-looking statements are subject to a number of risks and uncertainties, the Company's actual results could differ materially from those expressed or implied by these forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed under the heading "Risk Factors" in the Company's annual report on Form 10-K for the fiscal year ended December 31, 2008, filed with the United States Securities and Exchange Commission and available at www.sec.gov. The Company assumes no obligation to update any such forward-looking statements.

'/>"/>

SOURCE China Agri-Business, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5
Related biology technology :

1. China Biologic Products Announces Strong 2008 Results
2. ACM Global Central Lab Announces Partnership with Chindexs United Family Hospitals in China
3. China Biologic Products Completes Acquisition of 35% Interest in Xian Huitian Blood Products Co., Ltd.
4. China Bio Energy Reports Fourth Quarter and Record 2008 Financial Results
5. aTyr Pharma to Present at ChinaBio(R) Investor Forum in Hong Kong
6. Niusule Biotech Corp. Formally Establishes a New Venture to Import and Sell Health Foods in the Peoples Republic of China
7. China-Biotics, Inc. Appoints New Chief Financial Officer
8. China Medical Technologies Senior Management Purchased Company Shares
9. China Bio-Immunity Corporation - Rabies Vaccine Recall
10. China Medicine to Participate in 2009 Natural Products Expo West Trade Show
11. China Sky One Medical, Inc. Signs Exclusive Distribution Agreement with Shaanxi Buchang Group for Naftopidil Dispersible Tablets